- Home
- COEP vs HNNA Comparison
COEP vs HNNA Comparison
Compare COEP & HNNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COEP
- HNNA
- Stock Information
- Founded
- COEP 2017
- HNNA 1989
- Country
- COEP United States
- HNNA United States
- Employees
- COEP N/A
- HNNA N/A
- Industry
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- HNNA Investment Managers
- Sector
- COEP Health Care
- HNNA Finance
- Exchange
- COEP Nasdaq
- HNNA Nasdaq
- Market Cap
- COEP 86.0M
- HNNA 87.1M
- IPO Year
- COEP N/A
- HNNA N/A
- Fundamental
- Price
- COEP $15.29
- HNNA N/A
- Analyst Decision
- COEP
- HNNA
- Analyst Count
- COEP 0
- HNNA 0
- Target Price
- COEP N/A
- HNNA N/A
- AVG Volume (30 Days)
- COEP 66.5K
- HNNA 13.0K
- Earning Date
- COEP 11-12-2025
- HNNA 08-06-2025
- Dividend Yield
- COEP N/A
- HNNA 5.51%
- EPS Growth
- COEP N/A
- HNNA 56.56
- EPS
- COEP N/A
- HNNA 1.25
- Revenue
- COEP $263,555.00
- HNNA $35,816,000.00
- Revenue This Year
- COEP N/A
- HNNA N/A
- Revenue Next Year
- COEP N/A
- HNNA N/A
- P/E Ratio
- COEP N/A
- HNNA $7.84
- Revenue Growth
- COEP N/A
- HNNA 32.04
- 52 Week Low
- COEP $2.31
- HNNA $8.43
- 52 Week High
- COEP $19.19
- HNNA $13.88
- Technical
- Relative Strength Index (RSI)
- COEP 49.85
- HNNA 32.32
- Support Level
- COEP $14.90
- HNNA $9.62
- Resistance Level
- COEP $16.17
- HNNA $11.02
- Average True Range (ATR)
- COEP 1.17
- HNNA 0.45
- MACD
- COEP -0.30
- HNNA -0.03
- Stochastic Oscillator
- COEP 11.94
- HNNA 23.76
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
About HNNA Hennessy Advisors Inc.
Hennessy Advisors Inc is an investment management company, engaged in the managing and marketing of open-end mutual funds branded as the Hennessy Funds. It offers domestic equity, sectors, and specialty, balanced, and fixed income products. It also provides investment advisory services and shareholder services to the Hennessy Funds which include managing the composition of each fund's portfolio, including the purchase, retention, and disposition of portfolio securities as per the Fund's investment objectives, policies, and restrictions; conducting investment research, and monitoring compliance with each fund's investment restrictions and applicable laws and regulations.